Torrent Pharma calls the reports of Cipla acquisition as speculative

"As a policy we don't want to comment on speculative news," said Sudhir Mehta, chairman emeritus of Torrent Pharma, referring to reports about the race to acquire Cipla at the company's earnings call. Mehta said the company's capital allocation will be largely geared towards India.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/0SChQRU
via IFTTT